US Stock MarketDetailed Quotes

TECX Tectonic Therapeutic

Watchlist
  • 30.600
  • +2.020+7.07%
Close Sep 27 16:00 ET
  • 30.600
  • 0.0000.00%
Post 16:00 ET
450.88MMarket Cap-10408P/E (TTM)

Tectonic Therapeutic Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-8.48M
-121.91%-27.64M
-7.79M
-12.45M
Net income from continuing operations
---10.05M
-260.48%-32.18M
---10.29M
---8.93M
Operating gains losses
----
90.98%-643K
--0
---7.13M
Depreciation and amortization
--371K
176.37%1.01M
--322K
--364K
Other non cash items
--281K
80.15%1.23M
--269K
--680K
Change In working capital
--646K
-4.18%1.84M
--1.64M
--1.92M
-Change in prepaid assets
--570K
-102.15%-376K
---17K
---186K
-Change in payables and accrued expense
--429K
54.99%3.28M
--1.92M
--2.11M
-Change in other current assets
--7K
-27.27%-14K
--17K
---11K
-Change in other current liabilities
---360K
---1.05M
---280K
--0
Cash from discontinued investing activities
Operating cash flow
---8.48M
-121.91%-27.64M
---7.79M
---12.45M
Investing cash flow
Cash flow from continuing investing activities
-7K
1.60%-2.09M
-285K
-2.12M
Net PPE purchase and sale
---7K
1.60%-2.09M
---285K
---2.12M
Cash from discontinued investing activities
Investing cash flow
---7K
1.60%-2.09M
---285K
---2.12M
Financing cash flow
Cash flow from continuing financing activities
-114K
-9.15%37.63M
-119K
41.42M
Net issuance payments of debt
---114K
-110.88%-393K
---119K
--3.61M
Net preferred stock issuance
----
0.56%38.02M
--0
--37.81M
Proceeds from stock option exercised by employees
--0
100.00%4K
--0
--2K
Cash from discontinued financing activities
Financing cash flow
---114K
-9.15%37.63M
---119K
--41.42M
Net cash flow
Beginning cash position
--15.52M
1,486.38%28.65M
--44.75M
--1.81M
Current changes in cash
---8.6M
-70.56%7.9M
---8.2M
--26.84M
End cash Position
--6.92M
27.58%36.55M
--36.55M
--28.65M
Free cash flow
---8.49M
-103.93%-29.73M
---8.08M
---14.58M
Currency Unit
USD
USD
USD
USD
(Q3)Sep 30, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -8.48M-121.91%-27.64M-7.79M-12.45M
Net income from continuing operations ---10.05M-260.48%-32.18M---10.29M---8.93M
Operating gains losses ----90.98%-643K--0---7.13M
Depreciation and amortization --371K176.37%1.01M--322K--364K
Other non cash items --281K80.15%1.23M--269K--680K
Change In working capital --646K-4.18%1.84M--1.64M--1.92M
-Change in prepaid assets --570K-102.15%-376K---17K---186K
-Change in payables and accrued expense --429K54.99%3.28M--1.92M--2.11M
-Change in other current assets --7K-27.27%-14K--17K---11K
-Change in other current liabilities ---360K---1.05M---280K--0
Cash from discontinued investing activities
Operating cash flow ---8.48M-121.91%-27.64M---7.79M---12.45M
Investing cash flow
Cash flow from continuing investing activities -7K1.60%-2.09M-285K-2.12M
Net PPE purchase and sale ---7K1.60%-2.09M---285K---2.12M
Cash from discontinued investing activities
Investing cash flow ---7K1.60%-2.09M---285K---2.12M
Financing cash flow
Cash flow from continuing financing activities -114K-9.15%37.63M-119K41.42M
Net issuance payments of debt ---114K-110.88%-393K---119K--3.61M
Net preferred stock issuance ----0.56%38.02M--0--37.81M
Proceeds from stock option exercised by employees --0100.00%4K--0--2K
Cash from discontinued financing activities
Financing cash flow ---114K-9.15%37.63M---119K--41.42M
Net cash flow
Beginning cash position --15.52M1,486.38%28.65M--44.75M--1.81M
Current changes in cash ---8.6M-70.56%7.9M---8.2M--26.84M
End cash Position --6.92M27.58%36.55M--36.55M--28.65M
Free cash flow ---8.49M-103.93%-29.73M---8.08M---14.58M
Currency Unit USDUSDUSDUSD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data